Name That Brand: May 2012

Share this article:

Can you name the brand? Each month we print part of a popular pharmaceutical product or advertisement, with clues to its identity. Readers are invited to name the brand for a chance to win a copy of Medicine Ave 2: The Story of Medical Advertising in America 1990-2008. E-mail your answer to NameThatBrand@haymarketmedia.com or fax 646-638-6150. The deadline is May 31, 2012. The winner will be picked randomly from the correct entries.

 

Brand X lights up its message
Among 2010's most detailed products, May's drug also topped the list of most-likely-to-be-prescribed following a sales visit. The advertising for this physician favorite is a bit of a mixed metaphor, with two colors swirling upwards, while the two-part compound is in fact all about decline. And the brand's sales reps may have been working at cross purposes as well, with accusations that they offered off-label advice for the drug whose primary audience could include almost 68 million, or 1 in 3 adults.

MARCH'S WINNER...
No one was able to correctly identify March's Name That Brand. The answer was Merck's Victrelis, a prescription medicine indicated to treat chronic hepatitis C infections.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?